Tissue engineering

Guest Editor(s):

Hon Fai Chan: The Chinese University of Hong Kong, China
Kulwinder Kaur: Royal College of Surgeons in Ireland, Ireland
Subhadeep Roy: Indian Institute of Technology Delhi, India

Submission Status: Open | Submission Deadline: 30 April 2023

The Editors of BMC Biomedical Engineering and BMC Biotechnology are calling for submissions to our Cross-Journal Collection on Tissue Engineering. The collection aims to cover advances in biomaterials, stem cells, growth and differentiation factors, and biomimetic environments which are creating unique opportunities to fabricate or improve organic tissue engineering.

Submit to collection

BMC Biomedical Engineering

BMC Biotechnology

Meet the Guest Editors

Back to top

Hon Fai Chan: The Chinese University of Hong Kong, China

Hon Fai Chan is an Assistant Professor at the Institute for Tissue Engineering and Regenerative Medicine and the School of Biomedical Sciences at The Chinese University of Hong Kong (CUHK). Prof. Chan’s research mainly focuses on advancing biofabrication approaches and biomaterial design for stem cell tissue engineering and regenerative medicine, as well as understanding how microenvironmental cues influence stem cell proliferation and differentiation.

Kulwinder Kaur: Royal College of Surgeons in Ireland, Ireland
Kulwinder Kaur is a research Fellow at Marie Skłodowska-Curie Actions (MSCA) in RCSI, Dublin. Dr. Kaur’s main area of research is the synthesis of NanoEngineered Injectable Hydrogels for osteoporotic vertebral bone fractures and additionally has extensive experience in bone regeneration, biomaterials science, materials science, and in vitro studies.

Subhadeep Roy: Indian Institute of Technology Delhi, India
Subhadeep Roy is a Postdoctoral Research Associate at the Department of Fibre and Textile Engineering at the Regenerative Engineering Laboratory, Indian Institute of Technology, Delhi, India. His current research focuses on the modulation of biomaterial-mediated immune responses, macrophage polarization, decellularized extracellular matrix, and in vitro disease models. He has also worked as a visiting senior research fellow at the ID3S (Implant, Device, Drug, Drug Delivery System), Translational Health Science and Technology Institute, Faridabad, in targeted drug delivery of anti-tubercular formulation in human pulmonary macrophages.

About the collection

The Editors of BMC Biomedical Engineering and BMC Biotechnology announce the launch and call for research articles on Tissue Engineering.

Tissue engineering brings together multiple aspects of science, medicine and engineering. It starts from using cells as building blocks on scaffolds to large scale whole structures towards medicinal use. Scientific advances in biomaterials, stem cells, growth and differentiation factors, and biomimetic environments have created unique opportunities to fabricate or improve regenerative engineering. Different laboratories use combinations of engineered extracellular matrices ("scaffolds"), cells, and biologically active molecules to mimic the in vivo conditions. Among the major challenges now facing tissue engineering is the need for more complex functionality, biomechanical stability, and vascularization in laboratory-grown tissues destined for transplantation. There are also very few stringent protocols to judge the immunogenicity of different implantable biomaterials and extracellular matrices. The role of circulating monocytes and resident macrophages after implantation is still not completely understood, which makes the outcome more unpredictable. At this brink of breakthrough research, BMC Biotechnology and BMC Biomedical Engineering welcome submissions to their collection on Tissue engineering. The use of biomaterials in regenerative medicine for development of multiple lineages and specific organs will be covered. The special issue will consider different types of natural and synthetic biomaterial use for regenerative purposes. Innovative research on extracellular matrix and stem cells responsive biomaterials are welcome. Recent advancement and greater challenges in biomaterial mediated drug or small molecule delivery, additive manufacturing will be the major thrust here.

The broad areas of research covered by this collection include:

Advances in tissue culture including bio-reactors and bio-artificial organs.
Advances and developments in tissue assembly methods including techniques like 3D scaffolding and hydrogels
Bioprinting, nanofibres and nanomaterials
stem-cell -use in regenerative medicine
Isolation and purification of primary cells towards application
Lab-grown organs and tissues
Biomaterials in drug or small molecule delivery, Additive Manufacturing
Extracellular matrix, decellularization
Biodegradable nanomaterials including nano-polymers
Computational modeling in tissue engineering

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read the submission guidelines of the journal you are submitting to BMC Biomedical Engineering & BMC Biotechnology. Articles for this Collection should be submitted via our submission system, SNAPP BMC Biomedical Engineering & BMC Biotechnology. During the submission process you will be asked whether you are submitting to a Collection, please select "Tissue Engineering" from the dropdown menu.”

Articles will undergo the standard peer-review process of the journal they are considered in BMC Biomedical Engineering & BMC Biotechnology and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.